Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000226952

Medchemexpress LLC Ksc-34 | 2226201-97-2 | 99.9% | 429.95 | C21H28ClN7O | 25 MG
SDP

Catalog No. 5000226952
Encompass_Preferred

KSC-34 is a covalent modifier and selective a-site inhibitor of protein disulfide isomerase A1 (PDIA1), supplied as a high-purity research reagent. It contains an alkyne functional group enabling copper-catalyzed azide-alkyne cycloaddition (click chemistry) and is provided in multiple solid and solution formats for laboratory use.

  • Selective PDIA1 a-site inhibitor (IC50 ≈ 3.5 μM).
  • Contains an alkyne group for click chemistry applications.
  • High purity suitable for research use (~99.9%).
  • Available as solids (including 25 mg) and as a DMSO solution.
  • Supplied with supporting datasheet and SDS documentation.

Catalog No. 50-002-26952 Supplier Medchemexpress LLC Supplier No. HY11757025MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

KSC-34 is a covalent modifier and selective a-site inhibitor of protein disulfide isomerase A1 (PDIA1), supplied as a high-purity research reagent. It contains an alkyne functional group enabling copper-catalyzed azide-alkyne cycloaddition (click chemistry) and is provided in multiple solid and solution formats for laboratory use.

  • Selective PDIA1 a-site inhibitor (IC50 ≈ 3.5 μM).
  • Contains an alkyne group for click chemistry applications.
  • High purity suitable for research use (~99.9%).
  • Available as solids (including 25 mg) and as a DMSO solution.
  • Supplied with supporting datasheet and SDS documentation.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.